Skip to main content

Advertisement

Log in

Evolving Rhinology: Understanding the Burden of Chronic Rhinosinusitis Today, Tomorrow, and Beyond

  • Rhinosinusitis (J Mullol, Section Editor)
  • Published:
Current Allergy and Asthma Reports Aims and scope Submit manuscript

Abstract

Purpose of Review

To improve our appreciation of the burden of chronic rhinosinusitis (CRS) and to understand better how to ease that burden.

Recent Findings

The burden of CRS is high. At an individual level, this burden is due to rhinologic symptoms as well as more systemic symptoms. At a societal level, the indirect costs of CRS, mostly due to reduced productivity, are higher than the direct costs. Surgical treatment has been found to be effective in addressing both the individual and societal burdens. Endotyping is just beginning to usher in the potential for personalized, precision treatments in CRS.

Summary

We understand much about the burden of CRS but more remains to be learned, especially as newer expensive treatments become available. By appreciating the high burden of CRS, we can fulfill our mission to effectively lift that burden.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance

  1. Orlandi RR, Kingdom TT, Hwang PH, Smith TL, Alt JA, Baroody FM, et al. International consensus statement on allergy and rhinology: rhinosinusitis. Int Forum Allergy Rhinol. 2016;6(Suppl 1):S22–209.

    PubMed  Google Scholar 

  2. Fokkens WJ, Lund VJ, Mullol J, Bachert C, Alobid I, Baroody F, et al. European position paper on rhinosinusitis and nasal polyps 2020.  Rhinology. 2020;58(Suppl S29):1–464.

  3. Soler ZM, Hyer JM, Ramakrishnan V, Smith TL, Mace J, Rudmik L, et al. Identification of chronic rhinosinusitis phenotypes using cluster analysis. Int Forum Allergy Rhinol. 2015;5(5):399–407.

    Article  Google Scholar 

  4. Workman AD, Kohanski MA, Cohen NA. Biomarkers in chronic rhinosinusitis with nasal polyps. Immunol Allergy Clin N Am. 2018;38(4):679–92.

    Article  Google Scholar 

  5. •• Tomassen P, Vandeplas G, Van Zele T, Cardell LO, Arebro J, Olze H, et al. Inflammatory endotypes of chronic rhinosinusitis based on cluster analysis of biomarkers. J Allergy Clin Immunol. 2016;137(5):1449–56 e4. A leap forward in our understanding of endotypes based on inflammatory profiles.

    Article  CAS  Google Scholar 

  6. Hellings PW, Fokkens WJ, Bachert C, Akdis CA, Bieber T, Agache I, et al. Positioning the principles of precision medicine in care pathways for allergic rhinitis and chronic rhinosinusitis - a EUFOREA-ARIA-EPOS-AIRWAYS ICP statement. Allergy. 2017;72(9):1297–305.

    Article  CAS  Google Scholar 

  7. DeConde AS, Soler ZM. Chronic rhinosinusitis: epidemiology and burden of disease. Am J Rhinol Allergy. 2016;30(2):134–9.

    Article  Google Scholar 

  8. Bachert C, Zhang L, Gevaert P. Current and future treatment options for adult chronic rhinosinusitis: focus on nasal polyposis. J Allergy Clin Immunol. 2015;136(6):1431–40.

    Article  CAS  Google Scholar 

  9. Smith KA, Orlandi RR, Rudmik L. Cost of adult chronic rhinosinusitis: a systematic review. Laryngoscope. 2015;125(7):1547–56.

    Article  Google Scholar 

  10. •• Rudmik L. Economics of chronic rhinosinusitis. Curr Allergy Asthma Rep. 2017;17(4):20. An excellent summary of our current understanding of the costs of CRS.

    Article  Google Scholar 

  11. Rudmik L, Smith TL, Schlosser RJ, Hwang PH, Mace JC, Soler ZM. Productivity costs in patients with refractory chronic rhinosinusitis. Laryngoscope. 2014;124(9):2007–12.

    Article  Google Scholar 

  12. Anand VK. Epidemiology and economic impact of rhinosinusitis. Ann Otol Rhinol Laryngol Suppl. 2004;193:3–5.

    Article  Google Scholar 

  13. Bhattacharyya N. Functional limitations and workdays lost associated with chronic rhinosinusitis and allergic rhinitis. Am J Rhinol Allergy. 2012;26(2):120–2.

    Article  Google Scholar 

  14. Smith KA, Rudmik L. Impact of continued medical therapy in patients with refractory chronic rhinosinusitis. Int Forum Allergy Rhinol. 2014;4(1):34–8.

    Article  Google Scholar 

  15. Stankiewicz J, Tami T, Truitt T, Atkins J, Winegar B, Cink P, et al. Impact of chronic rhinosinusitis on work productivity through one-year follow-up after balloon dilation of the ethmoid infundibulum. Int Forum Allergy Rhinol. 2011;1(1):38–45.

    Article  Google Scholar 

  16. Tarasidis GS, DeConde AS, Mace JC, Ashby S, Smith TL, Orlandi RR, et al. Cognitive dysfunction associated with pain and quality of life in chronic rhinosinusitis. Int Forum Allergy Rhinol. 2015;5(11):1004–9.

    Article  Google Scholar 

  17. Chowdhury NI, Mace JC, Smith TL, Rudmik L. What drives productivity loss in chronic rhinosinusitis? A SNOT-22 subdomain analysis. Laryngoscope. 2018;128(1):23–30.

    Article  Google Scholar 

  18. • Smith KA, Ashby S, Orlandi RR, Oakley G, Alt JA. The price of pain in chronic rhinosinusitis. Int Forum Allergy Rhinol. 2018. https://doi.org/10.1002/alr.22128. This article demonstrates an association between pain, an often overlooked symptoms in CRS due to its poor diagnostic specificity, and productivity losses in CRS.

    Article  Google Scholar 

  19. Park DY, Lee EJ, Kim JH, Kim YS, Jung CM, Kim KS. Correlation between symptoms and objective findings may improve the symptom-based diagnosis of chronic rhinosinusitis for primary care and epidemiological studies. BMJ Open. 2015;5(12):e009541.

    Article  Google Scholar 

  20. Soler ZM, Wittenberg E, Schlosser RJ, Mace JC, Smith TL. Health state utility values in patients undergoing endoscopic sinus surgery. Laryngoscope. 2011;121(12):2672–8.

    Article  Google Scholar 

  21. Hoehle LP, Phillips KM, Bergmark RW, Caradonna DS, Gray ST, Sedaghat AR. Symptoms of chronic rhinosinusitis differentially impact general health-related quality of life. Rhinology. 2016;54(4):316–22.

    Article  CAS  Google Scholar 

  22. • Bachert C, Hellings PW, Mullol J, Hamilos DL, Gevaert P, Naclerio RM, et al. Dupilumab improves health-related quality of life in patients with chronic rhinosinusitis with nasal polyposis. Allergy. 2020;75(1):148–57. An article examining the effect of monoclonal antibiody “biologic” therapy, in this case focusing on patient-reported outcome measures.

    Article  CAS  Google Scholar 

  23. Fine PG. Long-term consequences of chronic pain: mounting evidence for pain as a neurological disease and parallels with other chronic disease states. Pain Med. 2011;12(7):996–1004.

    Article  Google Scholar 

  24. DeConde AS, Mace JC, Ashby S, Smith TL, Orlandi RR, Alt JA. Characterization of facial pain associated with chronic rhinosinusitis using validated pain evaluation instruments. Int Forum Allergy Rhinol. 2015;5(8):682–90.

    Article  Google Scholar 

  25. Cox DR, Ashby S, DeConde AS, Mace JC, Orlandi RR, Smith TL, et al. Dyad of pain and depression in chronic rhinosinusitis. Int Forum Allergy Rhinol. 2016;6(3):308–14.

    Article  Google Scholar 

  26. Cox DR, Ashby S, Mace JC, DelGaudio JM, Smith TL, Orlandi RR, et al. The pain-depression dyad and the association with sleep dysfunction in chronic rhinosinusitis. Int Forum Allergy Rhinol. 2017;7(1):56–63.

    Article  Google Scholar 

  27. Schlosser RJ, Gage SE, Kohli P, Soler ZM. Burden of illness: a systematic review of depression in chronic rhinosinusitis. Am J Rhinol Allergy. 2016;30(4):250–6.

    Article  Google Scholar 

  28. Alt JA, Smith TL, Mace JC, Soler ZM. Sleep quality and disease severity in patients with chronic rhinosinusitis. Laryngoscope. 2013;123(10):2364–70.

    PubMed  PubMed Central  Google Scholar 

  29. Alt JA, Ramakrishnan VR, Platt MP, Schlosser RJ, Storck T, Soler ZM. Impact of chronic rhinosinusitis on sleep: a controlled clinical study. Int Forum Allergy Rhinol. 2019;9(1):16–22.

    Article  Google Scholar 

  30. Chester AC, Sindwani R, Smith TL, Bhattacharyya N. Fatigue improvement following endoscopic sinus surgery: a systematic review and meta-analysis. Laryngoscope. 2008;118(4):730–9.

    Article  Google Scholar 

  31. Smith KA, Smith TL, Mace JC, Rudmik L. Endoscopic sinus surgery compared to continued medical therapy for patients with refractory chronic rhinosinusitis. Int Forum Allergy Rhinol. 2014;4(10):823–7.

    Article  Google Scholar 

  32. Smith TL, Kern R, Palmer JN, Schlosser R, Chandra RK, Chiu AG, et al. Medical therapy vs surgery for chronic rhinosinusitis: a prospective, multi-institutional study with 1-year follow-up. Int Forum Allergy Rhinol. 2013;3(1):4–9.

    Article  Google Scholar 

  33. •• Patel ZM, Thamboo A, Rudmik L, Nayak JV, Smith TL, Hwang PH. Surgical therapy vs continued medical therapy for medically refractory chronic rhinosinusitis: a systematic review and meta-analysis. Int Forum Allergy Rhinol. 2017;7(2):119–27. A thorough analysis of outcomes evidence regarding the relative efficacy of surgery compared to continued medical management, demonstrating the relative superiority of a surgical strategy in these patients.

    Article  Google Scholar 

  34. • Rudmik L, Soler ZM, Mace JC, Schlosser RJ, Smith TL. Economic evaluation of endoscopic sinus surgery versus continued medical therapy for refractory chronic rhinosinusitis. Laryngoscope. 2015;125(1):25–32. A rigorous economic analysis of endoscopic sinus surgery that demonstrates the relative supeiority of sinus surgery depending on quality adjusted life years and willingness to pay thresholds.

    Article  Google Scholar 

  35. • Scangas GA, Remenschneider AK, Su BM, Shrime MG, Metson R. Cost utility analysis of endoscopic sinus surgery for chronic rhinosinusitis with and without nasal polyposis. Laryngoscope. 2017;127(1):29–37. Another rigorous economic analysis of sinus surgery, using slightly different economic assumptions compared to Rudmik, et al (2015).

    Article  Google Scholar 

  36. Beswick DM, Mace JC, Rudmik L, Soler ZM, DeConde AS, Smith TL. Productivity changes following medical and surgical treatment of chronic rhinosinusitis by symptom domain. Int Forum Allergy Rhinol. 2018;8(12):1395–405.

    Article  Google Scholar 

  37. • Bachert C, Han JK, Desrosiers M, Hellings PW, Amin N, Lee SE, et al. Efficacy and safety of dupilumab in patients with severe chronic rhinosinusitis with nasal polyps (LIBERTY NP SINUS-24 and LIBERTY NP SINUS-52): results from two multicentre, randomised, double-blind, placebo-controlled, parallel-group phase 3 trials. Lancet. 2019;394(10209):1638–50. Early evidence that monoclonal antibody “biologic” therapy could have a significant impact on current and future treatment of CRS, with a focus on endoscopic and symptomatic findings.

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Richard R. Orlandi.

Ethics declarations

Conflict of Interest

The authors declare no conflicts of interest relevant to this manuscript.

Human and Animal Rights and Informed Consent

This article does not contain any studies with human or animal subjects performed by any of the authors.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

This article is part of the Topical Collection on Rhinosinusitis

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Yim, M.T., Orlandi, R.R. Evolving Rhinology: Understanding the Burden of Chronic Rhinosinusitis Today, Tomorrow, and Beyond. Curr Allergy Asthma Rep 20, 7 (2020). https://doi.org/10.1007/s11882-020-00904-w

Download citation

  • Published:

  • DOI: https://doi.org/10.1007/s11882-020-00904-w

Keywords

Navigation